Cell C suffers large loss as revenue declines

accreditation
0:00
play article
Subscribers can listen to this article
Cell C. (iStock)
Cell C. (iStock)
  • Blue Label, which wrote off its investment in Cell C, posted a 5% decline in revenue in 2022.
  • Cell C suffered a net loss before taxation of R2.3 billion.
  • The plan to restructure Cell C's debt burden of more than R7 billion is expected to be concluded by mid-September.
  • Get the biggest business stories emailed to you every weekday, or go to the Fin24 front page.

Blue Label Telecoms, a major shareholder in Cell C, saw its revenue decline by 5% to R17.8 billion in the year to end May.

Cell C's revenue fell from R13.95 billion in the previous year to R13.3 billion. It reported a net loss before tax of almost R2.5 billion.

Blue Label also provides a range of services, like bulk prepaid products to retailers, including starter packs SIM cards, prepaid airtime, and ticketing for events.

Its core headline earnings hit R1 billion, or 121.01 cents per share, up from 89.65 cents per share in the corresponding period in 2021. Gross profit increased by R548 million to R2.93 billion.

Net commissions earned on the distribution of prepaid electricity increased by R18 million to R298 million. 

The company said it continues to "increase market share and bolster its product and services mix to defend and grow its positions in the market."

As a result of the financial challenges faced by Cell C, Blue Label wrote off the carrying value of its 45% shareholding in the telecommunications company. The company paid R5.5 billion for the stake in 2017. Cell C is struggling with a debt burden of R7.3 billion.

The long-delayed recapitalisation of Cell C is expected to be concluded by mid-September. Blue Label said the business is still regarded as a going concern.

The current financial statements received a qualified audit opinion, due to the "inability to obtain sufficient appropriate audit evidence to support the use of the going concern assumption" for Cell C - as the recapitalisation and restructuring of the operations are still in progress. 

The company stressed that the matter has no impact on its financial statements due to the investment in Cell C being fully impaired in prior periods.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Rand - Dollar
17.26
-0.3%
Rand - Pound
21.36
+0.0%
Rand - Euro
18.74
-0.1%
Rand - Aus dollar
12.22
+0.1%
Rand - Yen
0.13
-0.3%
Platinum
1,013.48
+0.1%
Palladium
1,639.75
-0.4%
Gold
1,928.37
-0.0%
Silver
23.71
+0.5%
Brent Crude
86.66
-0.9%
Top 40
73,867
-1.2%
All Share
79,899
-1.1%
Resource 10
77,031
-1.1%
Industrial 25
102,239
-1.6%
Financial 15
16,240
-0.3%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders